SELLAS Life Sciences (SLS) Net Equity Issued and Repurchased (2011 - 2026)
SELLAS Life Sciences (SLS) recorded Net Equity Issued and Repurchased of $38.82 million in Q2 2026, up 822.3% from $4.21 million a year earlier but down 12.0% from the prior quarter.
SELLAS Life Sciences (SLS) Net Equity Issued and Repurchased (2011 - 2026) Analysis & Trends
On a TTM basis, SELLAS Life Sciences' Net Equity Issued and Repurchased came in at $129.25 million as of Jun 30, 2026; for FY2025, it was $51.04 million.
- Annual Net Equity Issued and Repurchased has a five-year compound annual growth rate of 11.5% (FY2020 to FY2025).
- Across earlier years, Net Equity Issued and Repurchased came in at $560,000 in FY2024 (+93.8%), $289,000 in FY2023 (-72.4%), $1.05 million in FY2022 (-88.4%) and $9.01 million in FY2021 (-69.6%).
- Quarterly Net Equity Issued and Repurchased has ranged from $1,000 in Q4 2024 to $44.1 million in Q1 2026 over the past five years.
- Peak year-over-year performance for Net Equity Issued and Repurchased in the last five years was growth of 886.3% in Q1 2025, against a decline of 100.0% in Q3 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at $44.1 million (Q1 2026), $29.02 million (Q4 2025) and $17.32 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | SELLAS Life Sciences | 2.49 Bn | 2.49 Bn | - | 38.82 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 38.82 Mn |
| Mar 31, 2026 | 44.10 Mn |
| Dec 31, 2025 | 29.02 Mn |
| Sep 30, 2025 | 17.32 Mn |
| Jun 30, 2025 | 4.21 Mn |
| Mar 31, 2025 | 503,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Sep 30, 2024 | 155,000.00 |
| Jun 30, 2024 | 353,000.00 |
| Mar 31, 2024 | 51,000.00 |
| Dec 31, 2023 | 21,000.00 |
| Mar 31, 2023 | 268,000.00 |
| Dec 31, 2022 | 929,000.00 |
| Sep 30, 2022 | 69,000.00 |
| Jun 30, 2022 | 3,000.00 |
| Mar 31, 2022 | 47,000.00 |
| Dec 31, 2021 | 5.99 Mn |
| Sep 30, 2021 | 2,000.00 |
| Jun 30, 2021 | 17,000.00 |
| Mar 31, 2021 | 3.00 Mn |
SELLAS Life Sciences Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=SLS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "SLS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=SLS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();